Cancro de mama (Galician Wikipedia)

Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (outubro de 1999). "A systematic review of genetic polymorphisms and breast cancer risk". Cancer Epidemiology, Biomarkers & Prevention 8 (10): 843–54. PMID 10548311.

actamedicaportuguesa.com

Saudade André, Ana Raquel Tomás, Ricardo Fonseca (2005). "Carcinoma da Mama: Determinação da Amplificação do HER2 por Hibridação in situ de Fluorescência (FISH)". Acta Med Port (18): 417–422.

ahrq.gov

United States Preventive Services Task Force. "Breast Cancer: Screening". Arquivado dende o orixinal o 16 de xuño de 2013. Consultado o 28 de agosto de 2015.

aicr.org

Marmot, M; Atinmo, T; Byers, T; Chen, J; Hirohata, T; Jackson, A; James, W; Kolonel, L; Kumanyika, S; Leitzmann, C; Mann, J; Powers, H; Reddy, K; Riboli, E; Rivera, JA; Schatzkin, A; Seidell, J; Shuker, D; Uauy, R; Willett, W; Zeisel, S (2007). AICR, ed. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective (PDF). World Cancer Research Fund / American Institute for Cancer Research (AICR) Expert Reports 2. Washington, DC. ISBN 9780972252225. Arquivado dende o orixinal (PDF) o 07 de maio de 2016. Consultado o 06 de abril de 2018.

archive.org

International Agency for Research on Cancer (2014). Organización Mundial da Saúde, ed. World Cancer Report 2014. pp. Capítulo 5.2. ISBN 92-832-0429-8.
Organización Mundial da Saúde, ed. (2014). World Cancer Report 2014. pp. Capítulo 1.1. ISBN 92-832-0429-8.
Aronowitz, Robert A. (2007). Unnatural history: breast cancer and American society. Cambridge: Cambridge University Press. pp. 22–24. ISBN 0-521-82249-1.
Olson, James Stuart (2002). Bathsheba's breast: women, cancer & history. Baltimore: The Johns Hopkins University Press. pp. 9–13. ISBN 0-8018-6936-6.
Yalom, Marilyn (1997). A history of the breast. Nova York: Alfred A. Knopf. p. 234. ISBN 0-679-43459-3.
Sulik, Gayle A. (2010). Pink Ribbon Blues: How Breast Cancer Culture Undermines Women's Health. Oxford University Press. pp. 200–3. ISBN 0-19-974045-3. OCLC 535493589.
Rettig, Richard A.; Peter D. Jacobson, Cynthia M. Farquhar, Wade M. Aubry (2007). False Hope: Bone Marrow Transplantation for Breast Cancer. Nova York: Oxford University Press. ISBN 978-0-19-518776-2.

archive.today

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (novembro de 2014). "Management of the menopause after breast cancer". C-Gyn 15. Arquivado dende o orixinal o 07 de abril de 2016. Consultado o 09 de abril de 2018.

asco.org

Massarut, S; Baldassare G, Belleti B, Reccanello S, D'Andrea S, Ezio C, Perin T, Roncadin M, Vaidya JS (2006). "Intraoperative radiotherapy impairs breast cancer cell motility induced by surgical wound fluid". J Clin Oncol 24 (18S): 10611. Arquivado dende o orixinal o 12 de xaneiro de 2012. Consultado o 09 de abril de 2018.

bloomberg.com

Arnst, Catherine (2007). Bloomberg Businessweek, ed. "A Gender Gap in Cancer". ISSN 0007-7135.

books.google.com

Saunders, Christobel; Jassal, Sunil (2009). Breast cancer. Oxford: Oxford University Press. p. Capítulo 13. ISBN 978-0-19-955869-8.
McCann, Judith A. Shilling (2008). Lippincott Williams & Wilkins, ed. Nursing. Ambler. p. 99. ISBN 978-1-58255-668-0.

breastcancercare.org.uk

Breast Cancer Care UK (ed.). "Prognosis". Consultado o 27 de xuño de 2016.

bvs.br

files.bvs.br

Magno Belém Cirqueira, Marise Amaral Rebouças Moreira, Leonardo Ribeiro Soares, Ruffo Freitas-Júnior (2011). "Subtipos moleculares do câncer de mama" (PDF). FEMINA (revisão) 39 (10): 499–503.

cancer.gov

National Cancer Institute (2014). "Breast Cancer". Consultado o 29 de xuño de 2014.
National Cancer Insitute (2014). "Breast Cancer Treatment". Consultado o 29 de xuño de 2014.
National Cancer Institute (2014). "Breast Cancer Treatment". Consultado o 29 de xuño de 2014.
National Cancer Institute (2014). "Male Breast Cancer Treatment". Consultado o 29 de xuño de 2014.
National Cancer Institute (2004). "Metastatic Cancer: Questions and Answers". Arquivado dende o orixinal o 27 de agosto de 2008. Consultado o 6 de febreiro de 2008.

seer.cancer.gov

Cancer Stat Facts: Female Breast Cancer, U.S. National Cancer Institute, consultado o 16 de febreiro de 2018

cancer.net

American Society of Clinical Oncology, ed. (febreiro de 2016). "Diagnosis". Consultado o 29 de maio de 2016.
American Society of Clinical Oncology, ed. (febreiro de 2016). "Overview". Consultado o 30 de maio de 2016.
American Society of Clinical Oncology, ed. (febreiro de 2016). "Breast Cancer: Stages". Consultado o 19 de maio de 2016.
American Society of Clinical Oncology, ed. (febreiro de 2016). "Breast Cancer: Stages". Consultado o 9 de maio de 2016.
American Society of Clinical Oncology, ed. (febreiro de 2016). "Breast Cancer - Treatment Options". Consultado o 9 de maio de 2016.
American Society of Clinical Oncology (ed.). "Breast Cancer Treatment". Consultado o 27 de xuño de 2016.
American Society of Clinical Oncology (ed.). "Self Image and Cancer". Consultado o 21 de maio de 2016.
American Society of Clinical Oncology (ed.). "Anxiety". Consultado o 21 de maio de 2016.

cancer.org

American Cancer Society (2007). "Cancer Facts & Figures 2007" (PDF). Arquivado dende o orixinal (PDF) o 10 de abril de 2007. Consultado o 26 de abril de 2007.
American Cancer Society (2005). "Breast Cancer Facts & Figures 2005–2006" (PDF). Arquivado dende o orixinal (PDF) o 13 de xuño de 2007. Consultado o 26 de abril de 2007.
American Cancer Society, ed. (4 de maio de 2016). "How is breast cancer classified?". Arquivado dende o orixinal o 22 de xuño de 2016. Consultado o 21 de xuño de 2016.
American Cancer Society, ed. (4 de maio de 2016). "Can breast cancer be found early?". Arquivado dende o orixinal o 15 de xuño de 2016. Consultado o 23 de xuño de 2016.

cancernetwork.com

Peppercorn, J (2009). "Breast Cancer in Women Under 40". Oncology 23 (6): 465–474.

cancerresearchuk.org

Cancer Research UK (ed.). "Breast Cancer Staging". Arquivado dende o orixinal o 16 de maio de 2016. Consultado o 19 de maio de 2016.

cdc.gov

Centers for Disease Control and Prevention. "Screening".

crcfl.net

Riter, Bob (2010). Cancer Resource Center of the Finger Lakes, ed. "History of Breast Cancer Advocacy". Arquivado dende o orixinal o 23 de xuño de 2013. Consultado o 29 de xuño de 2013.

doi.org

dx.doi.org

Gøtzsche, PC; Jørgensen KJ (2013). "Screening for breast cancer with mammography.". The Cochrane database of systematic reviews 6. pp. CD001877. PMID 23737396. doi:10.1002/14651858.CD001877.pub5.
Watson, M (2008). "Assessment of suspected cancer". InnoAiT 1 (2). pp. 94–107. doi:10.1093/innovait/inn001.
Lacroix, M (2006). Bioscientifica, ed. "Significance, detection and markers of disseminated breast cancer cells". Endocrine-related Cancer 13 (4): 1033–67. PMID 17158753. doi:10.1677/ERC-06-0001.
Karakas, C (2011). "Paget's disease of the breast". Journal of carcinogenesis 10: 31. PMC 3263015. PMID 22279416. doi:10.4103/1477-3163.90676.
Hayes, James; Ricahrdson, Ann; Frampton, Chris (2013). "Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women". IMJ 43 (11): 1198–1204. PMID 23910051. doi:10.1111/imj.12256.
Reeder, JG; Vogel VG (2008). "Breast cancer prevention.". Cancer treatment and research 141: 149–64. PMID 18274088. doi:10.1007/978-0-387-73161-2_10.
Collaborative Group on Hormonal Factors in Breast Cancer (2002). "Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.". Lancet 360 (9328): 187–95. doi:10.1016/S0140-6736(02)09454-0.
Yager, JD; Davidson NE (2006). "Estrogen carcinogenesis in breast cancer". New Engl J Med 354 (3): 270–82. PMID 16421368. doi:10.1056/NEJMra050776.
Carroll, KK (1998). "Obesity as a risk factor for certain types of cancer". Lipids 33 (11): 1055–1059. doi:10.1007/s11745-998-0305-8.
Johnson, KC; Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, Cantor KP, Miller MD, Boyd NF, Millar J, Turcotte F (2011). "Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009).". Tobacco control 20 (1): e2. PMID 21148114. doi:10.1136/tc.2010.035931.
Lee, IM; Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT (2012). "Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy". The Lancet 380 (9838): 219–29. PMC 3645500. PMID 22818936. doi:10.1016/S0140-6736(12)61031-9.
Biswas, A; Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, Alter DA (2015). "Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults: A Systematic Review and Meta-analysis". Annals of Internal Medicine 162 (2): 123–32. PMID 25599350. doi:10.7326/M14-1651.
Boffetta, P; Hashibe M, La Vecchia C, Zatonski W, Rehm J (2006). "The burden of cancer attributable to alcohol drinking". International Journal of Cancer 119 (4): 884–7. PMID 16557583. doi:10.1002/ijc.21903.
Kaiser, J (2013). "Cancer. Cholesterol forges link between obesity and breast cancer.". Science 342 (6162): 1028. PMID 24288308. doi:10.1126/science.342.6162.1028.
Aceves, C; Anguiano B, Delgado G (2005). "Is iodine a gatekeeper of the integrity of the mammary gland?". Journal of Mammary Gland Biology and Neoplasia 10 (2): 189–96. PMID 16025225. doi:10.1007/s10911-005-5401-5.
Wang, XS; Armstrong ME, Cairns BJ, Key TJ, Travis RC (2011). "Shift work and chronic disease: the epidemiological evidence.". Occupational medicine (Oxford, England) 61 (2): 78–89. PMC 3045028. PMID 21355031. doi:10.1093/occmed/kqr001.
Brody, JG; Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S (2007). "Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?". Cancer 109 (12 Suppl): 2627–34. PMID 17503444. doi:10.1002/cncr.22656.
Ferro, Roberto (2012). "Pesticides and Breast Cancer". Advances in Breast Cancer Research 1 (3): 30–35. doi:10.4236/abcr.2012.13005.
Hendrick, RE (2010). "Radiation doses and cancer risks from breast imaging studies.". Radiology 257 (1): 246–53. PMID 20736332. doi:10.1148/radiol.10100570.
Kahlenborn, C; Modugno F, Potter DM, Severs WB (2006). "Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.". Mayo Clinic proceedings 81 (10): 1290–302. PMID 17036554. doi:10.4065/81.10.1290.
Casey, PM; Cerhan JR, Pruthi S (2008). "Oral contraceptive use and risk of breast cancer.". Mayo Clinic proceedings 83 (1): 86–90. PMID 18174010. doi:10.4065/83.1.86.
Iodice, S; Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P, Bernard L, Maisonneuve P, Gandini S (2010). "Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.". European journal of cancer 46 (12): 2275–84. PMID 20537530. doi:10.1016/j.ejca.2010.04.018.
Gaffield, ME; Culwell KR, Ravi A (2009). "Oral contraceptives and family history of breast cancer.". Contraception 80 (4): 372–80. PMID 19751860. doi:10.1016/j.contraception.2009.04.010.
Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T (agosto de 2006). "Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention". Biochimica et Biophysica Acta 1766 (1): 63–78. PMID 16675129. doi:10.1016/j.bbcan.2006.03.001.
Yang, L; Jacobsen KH (2008). "A systematic review of the association between breastfeeding and breast cancer.". Journal of Women's Health 17 (10): 1635–45. PMID 19049358. doi:10.1089/jwh.2008.0917.
Beral, V; Bull D, Doll R, Peto R, Reeves G (2004). "Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.". Lancet 363 (9414): 1007–16. PMID 15051280. doi:10.1016/S0140-6736(04)15835-2.
Gage, M; Wattendorf D, Henry LR (2012). "Translational advances regarding hereditary breast cancer syndromes". Journal of surgical oncology 105 (5): 444–51. PMID 22441895. doi:10.1002/jso.21856.
"Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.". Lancet 358 (9291): 1389–99. 2001. PMID 11705483. doi:10.1016/S0140-6736(01)06524-2.
Nelson, HD; Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL (2012). "Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.". Annals of Internal Medicine 156 (9): 635–48. PMC 3561467. PMID 22547473. doi:10.1059/0003-4819-156-9-201205010-00006.
Kouros-Mehr H, Kim JW, Bechis SK, Werb Z (abril de 2008). "GATA-3 and the regulation of the mammary luminal cell fate.". Current opinion in cell biology 20 (2): 164–70. PMC 2397451. PMID 18358709. doi:10.1016/j.ceb.2008.02.003.
Afonso, N; Bouwman D (2008). "Lobular carcinoma in situ". Eur. J. Cancer Prev. 17 (4): 312–6. PMID 18562954. doi:10.1097/CEJ.0b013e3282f75e5d.
Anothaisintawee, T; Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, Hirunpat S, Woodtichartpreecha P, Boonlikit S, Teerawattananon Y, Thakkinstian A (2013). "Risk factors of breast cancer: a systematic review and meta-analysis". Asian Pacific Journal of Public Health 25 (5): 368–387. PMID 23709491. doi:10.1177/1010539513488795.
Cunha S, Gano L, Morais GR, Thiemann T, Oliveira MC (2013). "Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy". J Steroid Biochem Mol Biol. (137): 223–41. doi:10.1016/j.jsbmb.2013.04.003.
Haslam SZ, Woodward TL (xuño de 2003). "Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland.". Breast Cancer Res. 5 (4): 208–15. PMC 165024. PMID 12817994. doi:10.1186/bcr615.
Wiseman BS, Werb Z (maio de 2002). "Stromal effects on mammary gland development and breast cancer". Science 296 (5570): 1046–9. PMC 2788989. PMID 12004111. doi:10.1126/science.1067431.
Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F (xaneiro de 2011). "Molecular mechanisms of leptin and adiponectin in breast cancer". Eur. J. Cancer 47 (1): 33–43. PMID 20889333. doi:10.1016/j.ejca.2010.09.005.
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL (xaneiro de 2008). "Variation of breast cancer risk among BRCA1/2 carriers". JAMA 299 (2): 194–201. PMC 2714486. PMID 18182601. doi:10.1001/jama.2007.55-a.
Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR (febreiro de 1998). "Involvement of Brca2 in DNA repair". Mol. Cell 1 (3): 347–57. PMID 9660919. doi:10.1016/S1097-2765(00)80035-0.
Marietta C, Thompson LH, Lamerdin JE, Brooks PJ (maio de 2009). "Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis". Mutat. Res. 664 (1–2): 77–83. PMC 2807731. PMID 19428384. doi:10.1016/j.mrfmmm.2009.03.011.
Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ (2005). "Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde". Nucleic Acids Res. 33 (11): 3513–20. PMC 1156964. PMID 15972793. doi:10.1093/nar/gki661.
Wooster R, Weber BL (xuño de 2003). "Breast and ovarian cancer". N. Engl. J. Med. 348 (23): 2339–47. PMID 12788999. doi:10.1056/NEJMra012284.
Saslow, D; Hannan J, Osuch J, Alciati MH, Baines C, Barton M, Bobo JK, Coleman C, Dolan M, Gaumer G, Kopans D, Kutner S, Lane DS, Lawson H, Meissner H, Moorman C, Pennypacker H, Pierce P, Sciandra E, Smith R, Coates R (2004). "Clinical breast examination: practical recommendations for optimizing performance and reporting". CA: a cancer journal for clinicians 54 (6): 327–344. PMID 15537576. doi:10.3322/canjclin.54.6.327.
Yu, YH; Liang C, Yuan XZ (2010). "Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review.". Breast cancer research and treatment 120 (2): 469–79. PMID 20130983. doi:10.1007/s10549-010-0750-1.
Li CI; Uribe DJ; Daling JR (2005). "Clinical characteristics of different histologic types of breast cancer.". Br J Cancer 93 (9): 1046. doi:10.1038/sj.bjc.6602787.
Elston, CW; Ellis IO (1991). "Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up". Histopathology 19 (5): 403–10. PMID 1757079. doi:10.1111/j.1365-2559.1991.tb00229.x.
Eliassen, AH; Hankinson SE, Rosner B, Holmes MD, Willett WC (2010). "Physical activity and risk of breast cancer among postmenopausal women". Arch. Intern. Med. 170 (19): 1758–64. PMC 3142573. PMID 20975025. doi:10.1001/archinternmed.2010.363.
Zheng, JS; Hu XJ, Zhao YM, Yang J, Li D (2013). "Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies". BMJ 346: f3706. PMID 23814120. doi:10.1136/bmj.f3706.
Wu, AH; Yu, MC; Tseng, CC; Pike, MC (2008). "Epidemiology of soy exposures and breast cancer risk.". British journal of cancer 98 (1): 9–14. PMID 18182974. doi:10.1038/sj.bjc.6604145.
Hartmann, LC; Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999). "Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer". N Engl J Med 340 (2): 77–84. PMID 9887158. doi:10.1056/NEJM199901143400201.
Meijers-Heijboer, H; van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001). "Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 and BRCA2 mutations". N Engl J Med 345 (3): 159–164. PMID 11463009. doi:10.1056/NEJM200107193450301.
Lostumbo, L; Carbine, NE; Wallace, J (2010). "Prophylactic mastectomy for the prevention of breast cancer.". The Cochrane database of systematic reviews (11): CD002748. PMID 21069671. doi:10.1002/14651858.CD002748.pub3.
Moyer, VA; U.S. Preventive Services Task Force (2013). "Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine 160: 271–281. doi:10.7326/M13-2747.
Nelson, HD; Smith ME, Griffin JC, Fu R (2013). "Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.". Annals of Internal Medicine 158 (8): 604–14. PMID 23588749. doi:10.7326/0003-4819-158-8-201304160-00005.
Cuzick, J; Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix AZ, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL (2013). "Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data". The Lancet 381 (9880): 1827–34. PMID 23639488. doi:10.1016/S0140-6736(13)60140-3.
Moyer, VA (2013). "Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.". Annals of Internal Medicine. PMID 24061472. doi:10.7326/0003-4819-159-10-201311190-00718.
Biesheuvel, C; Weigel S, Heindel W (2011). "Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries.". Breast care (Basel, Switzerland) 6 (2): 104–109. PMID 21673820. doi:10.1159/000327493.
Croswell JM, Kramer BS, Kreimer AR (2009). "Cumulative incidence of false-positive results in repeated, multimodal cancer screening". Annals of Family Medicine 7 (3): 212–22. PMC 2682972. PMID 19433838. doi:10.1370/afm.942.
Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K (2005). "Comparing the performance of mammography screening in the USA and the UK". Journal of Medical Screening 12 (1): 50–4. PMID 15814020. doi:10.1258/0969141053279130.
Welch, H Gilbert (2006). "Ramifications of screening for breast cancer". British Medical Journal 332 (7543). PMC 1410868. doi:10.1136/bmj.332.7543.727.
"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.". Annals of internal medicine 151 (10): 716–26, W–236. 2009. PMID 19920272. doi:10.1059/0003-4819-151-10-200911170-00008. Arquivado dende o orixinal o 02 de xaneiro de 2013. Consultado o 03 de abril de 2018.
Kösters, JP; Gøtzsche PC (2003). "Regular self-examination or clinical examination for early detection of breast cancer.". Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373.
Kösters JP, Gøtzsche PC (2003). "Regular self-examination or clinical examination for early detection of breast cancer". Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373.
Saslow D, Hannan J, Osuch J; et al. (2004). "Clinical breast examination: practical recommendations for optimizing performance and reporting". CA Cancer J Clin 54 (6): 327–44. PMID 15537576. doi:10.3322/canjclin.54.6.327.
Welch, HG, Passow HJ (2013). "Quantifying the Benefits and Harms of Screening Mammography.". JAMA internal medicine 174 (3): 448–54. PMID 24380095. doi:10.1001/jamainternmed.2013.13635.
Gøtzsche, PC; Nielsen M (2011). "Screening for breast cancer with mammography". Cochrane Database Syst Rev (1): CD001877. PMID 21249649. doi:10.1002/14651858.CD001877.pub4.
Saini, KS; Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, Piccart-Gebhart MJ, de Azambuja E (2011). "Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries". Annals of Oncology 23 (4): 853–9. PMID 21821551. doi:10.1093/annonc/mdr352.
Belletti, B; Vaidya JS, D'Andrea S, Entschladen F, Roncadin M, Lovat F, Berton S, Perin T, Candiani E, Reccanello S, Veronesi A, Canzonieri V, Trovò MG, Zaenker KS, Colombatti A, Baldassarre G, Massarut S (2008). "Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding". Clin. Cancer Res. 14 (5): 1325–32. PMID 18316551. doi:10.1158/1078-0432.CCR-07-4453.
Vaidya, JS; Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sütterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M (2010). "Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial". Lancet 376 (9735): 91–102. PMID 20570343. doi:10.1016/S0140-6736(10)60837-9.
Burstein, HJ; Temin, S; Anderson, H; Buchholz, TA; Davidson, NE; Gelmon, KE; Giordano, SH; Hudis, CA; Rowden, D; Solky, AJ; Stearns, V; Winer, EP; Griggs, JJ (2014). "Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.". Journal of clinical oncology : official journal of the American Society of Clinical Oncology 32 (21): 2255–69. PMID 24868023. doi:10.1200/JCO.2013.54.2258.
Bao, Ting; Rudek, Michelle A (2011). "The Clinical Pharmacology of Anastrozole". European Oncology & Haematology 7 (2): 106–8. doi:10.17925/EOH.2011.07.02.106. Arquivado dende o orixinal o 19 de abril de 2012. Consultado o 09 de abril de 2018.
EBCTCG, Early Breast Cancer Trialists' Collaborative Group (2015). "Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials". The Lancet. doi:10.1016/S0140-6736(15)61074-1.
Petit, T; Dufour P, Tannock I (2011). "A critical evaluation of the role of aromatase inhibitors as adjuvant therapy for postmenopausal women with breast cancer". Endocr. Relat. Cancer 18 (3): R79–89. PMID 21502311. doi:10.1530/ERC-10-0162.
Jahanzeb, M (2008). "Adjuvant trastuzumab therapy for HER2-positive breast cancer". Clin. Breast Cancer 8 (4): 324–33. PMID 18757259. doi:10.3816/CBC.2008.n.037.
Gonzalez-Angulo, AM; Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN (2009). "High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller". J. Clin. Oncol. 27 (34): 5700–6. PMC 2792998. PMID 19884543. doi:10.1200/JCO.2009.23.2025.
Gierach, GL; Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME (2012). "Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium". Journal of National Cancer Institute 104 (16): 1218–27. PMID 22911616. doi:10.1093/jnci/djs327.
Klein, Judith; Ji M, Rea NK, Stoodt G (2011). "Differences in male breast cancer stage, tumor size at diagnosis, and survival rate between metropolitan and nonmetropolitan regions". Am J Mens Health. 5 (5): 430–7. doi:10.1177/1557988311400403.
McGuire, A; Brown, JA; Malone, C; McLaughlin, R; Kerin, MJ (22 de maio de 2015). "Effects of age on the detection and management of breast cancer.". Cancers 7 (2): 908–29. PMC 4491690. PMID 26010605. doi:10.3390/cancers7020815.
Ramon Luengo-Fernandez, Jose Leal, Alastair Gray, Richard Sullivan (2013). "Economic burden of cancer across the European Union: a population-based cost analysis". The Lancet Oncology 14 (12): 1165–1174. doi:10.1016/S1470-2045(13)70442-X.

emedicine.com

eMedicine (2006). "Breast Cancer Evaluation". Arquivado dende o orixinal o 12 de febreiro de 2008. Consultado o 5 de febreiro de 2008.

esmo.org

Bouche, Gauthier; Piccart, Martine; Pestalozzi, Bernhard; Catane, Raphael (2013). Anticancer Fund, ed. Cancro da Mama: Um Guia Para o Doente (PDF) (3ª ed.). p. 12. Arquivado dende o orixinal (PDF) o 06 de setembro de 2015. Consultado o 05 de abril de 2018.

europepmc.org

Finocchi, L; Covarelli P, Rulli A, Servoli A, Noya G (2008). "Bilateral phylloid cystosarcoma of the breast: a case report and review of the literature". Chirurgia Italiana 60: 867–872. PMID 19256279.

fspog.com

José Agostinho Santos (2013). "Auto-exame da mama no rastreio do cancro mamário: soma-se a evidência, apaga-se a incerteza" (PDF). Acta Obstet Ginecol Port 7 (2): 113–117.
Araújo, Andreia Monteiro; Centeno, Mónica (2010). "Cancro da mama associado à gravidez" (PDF). Acta Obstet Ginecol Port 4 (1): 44–52.

guardian.co.uk

Browne, Anthony (2001). The Guardian, ed. "Cancer bias puts breasts first". Londres.

herceptin.com

Herceptin.com (ed.). "Herceptin (trastuzumab) Adjuvant HER2+ Breast Cancer Therapy Pivotal Studies and Efficacy Data". Arquivado dende o orixinal o 18 de xullo de 2011. Consultado o 8 de maio de 2010.

iarc.fr

International Agency for Research on Cancer (2008). "World Cancer Report" (PDF). Arquivado dende o orixinal (PDF) o 20 de xullo de 2011. Consultado o 26 de febreiro de 2011.

globocan.iarc.fr

OMS, Organización Mundial da Saúde (2012). Who.int, ed. "Breast Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012". Consultado o 30 de agosto de 2015.

imaginis.com

Imaginis Corporation, ed. (2006). "Breast Cancer: Statistics on Incidence, Survival, and Screening". Arquivado dende o orixinal o 24 de outubro de 2006. Consultado o 9 de outubro de 2006.

independent.co.uk

Laurance, Jeremy (29 de setembro de 2006). The Independent, ed. "Breast cancer cases rise 80% since Seventies". London. Arquivado dende o orixinal o 25 de abril de 2008. Consultado o 9 de outubro de 2006.

latimes.com

articles.latimes.com

Aschwanden, Christie (2007). Los Angeles Times, ed. "The trouble with mammograms". Consultado o 3 de setembro de 2015.

ligacontracancro.pt

Liga Portuguesa contra o Cancro (2015). "Sinais e sintomas do cancro da mama". Arquivado dende o orixinal o 09 de setembro de 2015. Consultado o 23 de agosto de 2015.

mayoclinicproceedings.org

Casey, PM; Cerhan JR, Pruthi S (2008). "Oral contraceptive use and risk of breast cancer.". Mayo Clinic proceedings 83 (1): 86–90. PMID 18174010. doi:10.4065/83.1.86.

merckmanuals.com

Merck Manual (2003). "Breast Disorders: Breast Cancer". Consultado o 5 de febreiro de 2008.
Merck Manual (2003). "Breast Disorders: Overview of Breast Disorders". Arquivado dende o orixinal o 03 de outubro de 2011. Consultado o 5 de febreiro de 2008.
Merck Manual (2015). "Breast Cancer". Consultado o 26 de agosto de 2015.
Kosir, Mary Ann (2013). Manual Merck, ed. "Breast Cancer: Breast Disorders: Merck Manual Professional". Consultado o 30 de agosto de 2015.

min-saude.pt

croc.min-saude.pt

João Moura Pereira (ed.). Cancro da Mama: Protocolo de diagnóstico, terapêutica e seguimento (PDF). IPO Coimbra. p. 50. Arquivado dende o orixinal (PDF) o 04 de agosto de 2016. Consultado o 07 de abril de 2018.
Pereira, João Moura; et al. (2012). Instituto Português de Oncologia de Coimbra, ed. Cancro da Mama: Protocolo de diagnóstico, terapêutica e seguimento (PDF). Arquivado dende o orixinal (PDF) o 04 de agosto de 2016. Consultado o 07 de abril de 2018.

nih.gov

ncbi.nlm.nih.gov

Gøtzsche, PC; Jørgensen KJ (2013). "Screening for breast cancer with mammography.". The Cochrane database of systematic reviews 6. pp. CD001877. PMID 23737396. doi:10.1002/14651858.CD001877.pub5.
Nelson, HD; Tyne, K; Naik, A; Bougatsos, C; Chan, B; Nygren, P; Humphrey, L (2009). "Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force". PMID 20722173.
Lacroix, M (2006). Bioscientifica, ed. "Significance, detection and markers of disseminated breast cancer cells". Endocrine-related Cancer 13 (4): 1033–67. PMID 17158753. doi:10.1677/ERC-06-0001.
Karakas, C (2011). "Paget's disease of the breast". Journal of carcinogenesis 10: 31. PMC 3263015. PMID 22279416. doi:10.4103/1477-3163.90676.
Finocchi, L; Covarelli P, Rulli A, Servoli A, Noya G (2008). "Bilateral phylloid cystosarcoma of the breast: a case report and review of the literature". Chirurgia Italiana 60: 867–872. PMID 19256279.
Hayes, James; Ricahrdson, Ann; Frampton, Chris (2013). "Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women". IMJ 43 (11): 1198–1204. PMID 23910051. doi:10.1111/imj.12256.
Reeder, JG; Vogel VG (2008). "Breast cancer prevention.". Cancer treatment and research 141: 149–64. PMID 18274088. doi:10.1007/978-0-387-73161-2_10.
Yager, JD; Davidson NE (2006). "Estrogen carcinogenesis in breast cancer". New Engl J Med 354 (3): 270–82. PMID 16421368. doi:10.1056/NEJMra050776.
Johnson, KC; Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, Cantor KP, Miller MD, Boyd NF, Millar J, Turcotte F (2011). "Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009).". Tobacco control 20 (1): e2. PMID 21148114. doi:10.1136/tc.2010.035931.
Lee, IM; Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT (2012). "Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy". The Lancet 380 (9838): 219–29. PMC 3645500. PMID 22818936. doi:10.1016/S0140-6736(12)61031-9.
Biswas, A; Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, Alter DA (2015). "Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults: A Systematic Review and Meta-analysis". Annals of Internal Medicine 162 (2): 123–32. PMID 25599350. doi:10.7326/M14-1651.
Blackburn, GL; Wang KA (2007). "Dietary fat reduction and breast cancer outcome: results from the Women's Intervention Nutrition Study (WINS).". The American journal of clinical nutrition 86 (3): s878–81. PMID 18265482.
Boffetta, P; Hashibe M, La Vecchia C, Zatonski W, Rehm J (2006). "The burden of cancer attributable to alcohol drinking". International Journal of Cancer 119 (4): 884–7. PMID 16557583. doi:10.1002/ijc.21903.
Kaiser, J (2013). "Cancer. Cholesterol forges link between obesity and breast cancer.". Science 342 (6162): 1028. PMID 24288308. doi:10.1126/science.342.6162.1028.
Aceves, C; Anguiano B, Delgado G (2005). "Is iodine a gatekeeper of the integrity of the mammary gland?". Journal of Mammary Gland Biology and Neoplasia 10 (2): 189–96. PMID 16025225. doi:10.1007/s10911-005-5401-5.
Wang, XS; Armstrong ME, Cairns BJ, Key TJ, Travis RC (2011). "Shift work and chronic disease: the epidemiological evidence.". Occupational medicine (Oxford, England) 61 (2): 78–89. PMC 3045028. PMID 21355031. doi:10.1093/occmed/kqr001.
Brody, JG; Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S (2007). "Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?". Cancer 109 (12 Suppl): 2627–34. PMID 17503444. doi:10.1002/cncr.22656.
Hendrick, RE (2010). "Radiation doses and cancer risks from breast imaging studies.". Radiology 257 (1): 246–53. PMID 20736332. doi:10.1148/radiol.10100570.
Kahlenborn, C; Modugno F, Potter DM, Severs WB (2006). "Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.". Mayo Clinic proceedings 81 (10): 1290–302. PMID 17036554. doi:10.4065/81.10.1290.
Casey, PM; Cerhan JR, Pruthi S (2008). "Oral contraceptive use and risk of breast cancer.". Mayo Clinic proceedings 83 (1): 86–90. PMID 18174010. doi:10.4065/83.1.86.
Iodice, S; Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P, Bernard L, Maisonneuve P, Gandini S (2010). "Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.". European journal of cancer 46 (12): 2275–84. PMID 20537530. doi:10.1016/j.ejca.2010.04.018.
Gaffield, ME; Culwell KR, Ravi A (2009). "Oral contraceptives and family history of breast cancer.". Contraception 80 (4): 372–80. PMID 19751860. doi:10.1016/j.contraception.2009.04.010.
Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T (agosto de 2006). "Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention". Biochimica et Biophysica Acta 1766 (1): 63–78. PMID 16675129. doi:10.1016/j.bbcan.2006.03.001.
Yang, L; Jacobsen KH (2008). "A systematic review of the association between breastfeeding and breast cancer.". Journal of Women's Health 17 (10): 1635–45. PMID 19049358. doi:10.1089/jwh.2008.0917.
Russo, J; Russo IH (1980). "Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence". Am J Pathol 100 (2): 505–506. PMC 1903536. PMID 6773421. In contrast, abortion is associated with increased risk of carcinomas of the breast. The explanation for these epidemiologic findings is not known, but the parallelism between the DMBA-induced rat mammary carcinoma model and the human situation is striking. ... Abortion would interrupt this process, leaving in the gland undifferentiated structures like those observed in the rat mammary gland, which could render the gland again susceptible to carcinogenesis.
Beral, V; Bull D, Doll R, Peto R, Reeves G (2004). "Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.". Lancet 363 (9414): 1007–16. PMID 15051280. doi:10.1016/S0140-6736(04)15835-2.
Gage, M; Wattendorf D, Henry LR (2012). "Translational advances regarding hereditary breast cancer syndromes". Journal of surgical oncology 105 (5): 444–51. PMID 22441895. doi:10.1002/jso.21856.
"Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.". Lancet 358 (9291): 1389–99. 2001. PMID 11705483. doi:10.1016/S0140-6736(01)06524-2.
Nelson, HD; Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL (2012). "Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.". Annals of Internal Medicine 156 (9): 635–48. PMC 3561467. PMID 22547473. doi:10.1059/0003-4819-156-9-201205010-00006.
Kouros-Mehr H, Kim JW, Bechis SK, Werb Z (abril de 2008). "GATA-3 and the regulation of the mammary luminal cell fate.". Current opinion in cell biology 20 (2): 164–70. PMC 2397451. PMID 18358709. doi:10.1016/j.ceb.2008.02.003.
Afonso, N; Bouwman D (2008). "Lobular carcinoma in situ". Eur. J. Cancer Prev. 17 (4): 312–6. PMID 18562954. doi:10.1097/CEJ.0b013e3282f75e5d.
Anothaisintawee, T; Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, Hirunpat S, Woodtichartpreecha P, Boonlikit S, Teerawattananon Y, Thakkinstian A (2013). "Risk factors of breast cancer: a systematic review and meta-analysis". Asian Pacific Journal of Public Health 25 (5): 368–387. PMID 23709491. doi:10.1177/1010539513488795.
Williams C, Edvardsson K, Lewandowski SA, Stram A, Gustafsson JA. (2008). "A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.". Oncogene (27): 1019–1032.
Haslam SZ, Woodward TL (xuño de 2003). "Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland.". Breast Cancer Res. 5 (4): 208–15. PMC 165024. PMID 12817994. doi:10.1186/bcr615.
Wiseman BS, Werb Z (maio de 2002). "Stromal effects on mammary gland development and breast cancer". Science 296 (5570): 1046–9. PMC 2788989. PMID 12004111. doi:10.1126/science.1067431.
Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F (xaneiro de 2011). "Molecular mechanisms of leptin and adiponectin in breast cancer". Eur. J. Cancer 47 (1): 33–43. PMID 20889333. doi:10.1016/j.ejca.2010.09.005.
Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (outubro de 1999). "A systematic review of genetic polymorphisms and breast cancer risk". Cancer Epidemiology, Biomarkers & Prevention 8 (10): 843–54. PMID 10548311.
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL (xaneiro de 2008). "Variation of breast cancer risk among BRCA1/2 carriers". JAMA 299 (2): 194–201. PMC 2714486. PMID 18182601. doi:10.1001/jama.2007.55-a.
Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR (febreiro de 1998). "Involvement of Brca2 in DNA repair". Mol. Cell 1 (3): 347–57. PMID 9660919. doi:10.1016/S1097-2765(00)80035-0.
Marietta C, Thompson LH, Lamerdin JE, Brooks PJ (maio de 2009). "Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis". Mutat. Res. 664 (1–2): 77–83. PMC 2807731. PMID 19428384. doi:10.1016/j.mrfmmm.2009.03.011.
Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ (2005). "Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde". Nucleic Acids Res. 33 (11): 3513–20. PMC 1156964. PMID 15972793. doi:10.1093/nar/gki661.
Wooster R, Weber BL (xuño de 2003). "Breast and ovarian cancer". N. Engl. J. Med. 348 (23): 2339–47. PMID 12788999. doi:10.1056/NEJMra012284.
Saslow, D; Hannan J, Osuch J, Alciati MH, Baines C, Barton M, Bobo JK, Coleman C, Dolan M, Gaumer G, Kopans D, Kutner S, Lane DS, Lawson H, Meissner H, Moorman C, Pennypacker H, Pierce P, Sciandra E, Smith R, Coates R (2004). "Clinical breast examination: practical recommendations for optimizing performance and reporting". CA: a cancer journal for clinicians 54 (6): 327–344. PMID 15537576. doi:10.3322/canjclin.54.6.327.
Yu, YH; Liang C, Yuan XZ (2010). "Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review.". Breast cancer research and treatment 120 (2): 469–79. PMID 20130983. doi:10.1007/s10549-010-0750-1.
Carlson, RW; Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC (2009). "Breast cancer. Clinical practice guidelines in oncology". Journal of the National Comprehensive Cancer Network : JNCCN 7 (2): 122–192. PMID 19200416.
Elston, CW; Ellis IO (1991). "Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up". Histopathology 19 (5): 403–10. PMID 1757079. doi:10.1111/j.1365-2559.1991.tb00229.x.
Eliassen, AH; Hankinson SE, Rosner B, Holmes MD, Willett WC (2010). "Physical activity and risk of breast cancer among postmenopausal women". Arch. Intern. Med. 170 (19): 1758–64. PMC 3142573. PMID 20975025. doi:10.1001/archinternmed.2010.363.
Zheng, JS; Hu XJ, Zhao YM, Yang J, Li D (2013). "Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies". BMJ 346: f3706. PMID 23814120. doi:10.1136/bmj.f3706.
Wu, AH; Yu, MC; Tseng, CC; Pike, MC (2008). "Epidemiology of soy exposures and breast cancer risk.". British journal of cancer 98 (1): 9–14. PMID 18182974. doi:10.1038/sj.bjc.6604145.
Hartmann, LC; Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999). "Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer". N Engl J Med 340 (2): 77–84. PMID 9887158. doi:10.1056/NEJM199901143400201.
Meijers-Heijboer, H; van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001). "Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 and BRCA2 mutations". N Engl J Med 345 (3): 159–164. PMID 11463009. doi:10.1056/NEJM200107193450301.
Lostumbo, L; Carbine, NE; Wallace, J (2010). "Prophylactic mastectomy for the prevention of breast cancer.". The Cochrane database of systematic reviews (11): CD002748. PMID 21069671. doi:10.1002/14651858.CD002748.pub3.
Nelson, HD; Smith ME, Griffin JC, Fu R (2013). "Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.". Annals of Internal Medicine 158 (8): 604–14. PMID 23588749. doi:10.7326/0003-4819-158-8-201304160-00005.
Cuzick, J; Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix AZ, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL (2013). "Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data". The Lancet 381 (9880): 1827–34. PMID 23639488. doi:10.1016/S0140-6736(13)60140-3.
Moyer, VA (2013). "Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.". Annals of Internal Medicine. PMID 24061472. doi:10.7326/0003-4819-159-10-201311190-00718.
Biesheuvel, C; Weigel S, Heindel W (2011). "Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries.". Breast care (Basel, Switzerland) 6 (2): 104–109. PMID 21673820. doi:10.1159/000327493.
Croswell JM, Kramer BS, Kreimer AR (2009). "Cumulative incidence of false-positive results in repeated, multimodal cancer screening". Annals of Family Medicine 7 (3): 212–22. PMC 2682972. PMID 19433838. doi:10.1370/afm.942.
Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K (2005). "Comparing the performance of mammography screening in the USA and the UK". Journal of Medical Screening 12 (1): 50–4. PMID 15814020. doi:10.1258/0969141053279130.
Welch, H Gilbert (2006). "Ramifications of screening for breast cancer". British Medical Journal 332 (7543). PMC 1410868. doi:10.1136/bmj.332.7543.727.
"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.". Annals of internal medicine 151 (10): 716–26, W–236. 2009. PMID 19920272. doi:10.1059/0003-4819-151-10-200911170-00008. Arquivado dende o orixinal o 02 de xaneiro de 2013. Consultado o 03 de abril de 2018.
Kösters, JP; Gøtzsche PC (2003). "Regular self-examination or clinical examination for early detection of breast cancer.". Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373.
Nelson HD, Tyne K, Naik A; et al. (2009). Agency for Healthcare Research and Quality (US), ed. Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force. Rockville.
Kösters JP, Gøtzsche PC (2003). "Regular self-examination or clinical examination for early detection of breast cancer". Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373.
Saslow D, Hannan J, Osuch J; et al. (2004). "Clinical breast examination: practical recommendations for optimizing performance and reporting". CA Cancer J Clin 54 (6): 327–44. PMID 15537576. doi:10.3322/canjclin.54.6.327.
Nelson HD, Tyne K, Naik A; et al. (2009). Agency for Healthcare Research and Quality, ed. "Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force". Evidence Syntheses (74). .
Welch, HG, Passow HJ (2013). "Quantifying the Benefits and Harms of Screening Mammography.". JAMA internal medicine 174 (3): 448–54. PMID 24380095. doi:10.1001/jamainternmed.2013.13635.
Gøtzsche, PC; Nielsen M (2011). "Screening for breast cancer with mammography". Cochrane Database Syst Rev (1): CD001877. PMID 21249649. doi:10.1002/14651858.CD001877.pub4.
Saini, KS; Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, Piccart-Gebhart MJ, de Azambuja E (2011). "Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries". Annals of Oncology 23 (4): 853–9. PMID 21821551. doi:10.1093/annonc/mdr352.
Belletti, B; Vaidya JS, D'Andrea S, Entschladen F, Roncadin M, Lovat F, Berton S, Perin T, Candiani E, Reccanello S, Veronesi A, Canzonieri V, Trovò MG, Zaenker KS, Colombatti A, Baldassarre G, Massarut S (2008). "Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding". Clin. Cancer Res. 14 (5): 1325–32. PMID 18316551. doi:10.1158/1078-0432.CCR-07-4453.
Vaidya, JS; Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sütterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M (2010). "Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial". Lancet 376 (9735): 91–102. PMID 20570343. doi:10.1016/S0140-6736(10)60837-9.
Burstein, HJ; Temin, S; Anderson, H; Buchholz, TA; Davidson, NE; Gelmon, KE; Giordano, SH; Hudis, CA; Rowden, D; Solky, AJ; Stearns, V; Winer, EP; Griggs, JJ (2014). "Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.". Journal of clinical oncology : official journal of the American Society of Clinical Oncology 32 (21): 2255–69. PMID 24868023. doi:10.1200/JCO.2013.54.2258.
Petit, T; Dufour P, Tannock I (2011). "A critical evaluation of the role of aromatase inhibitors as adjuvant therapy for postmenopausal women with breast cancer". Endocr. Relat. Cancer 18 (3): R79–89. PMID 21502311. doi:10.1530/ERC-10-0162.
Jahanzeb, M (2008). "Adjuvant trastuzumab therapy for HER2-positive breast cancer". Clin. Breast Cancer 8 (4): 324–33. PMID 18757259. doi:10.3816/CBC.2008.n.037.
NCBI, National Center for Biotechnology Information (2015). "ERBB2 erb-b2 receptor tyrosine kinase 2 Homo sapiens (human)". Consultado o 28 de agosto de 2015.
Gonzalez-Angulo, AM; Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN (2009). "High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller". J. Clin. Oncol. 27 (34): 5700–6. PMC 2792998. PMID 19884543. doi:10.1200/JCO.2009.23.2025.
Gierach, GL; Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME (2012). "Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium". Journal of National Cancer Institute 104 (16): 1218–27. PMID 22911616. doi:10.1093/jnci/djs327.
McNaught J, Reid RL, Provencher DM (xullo de 2006). "Progesterone-only and non-hormonal contraception in the breast cancer survivor: Joint Review and Committee Opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada". J Obstet Gynaecol Can 28 (7): 616–39. PMID 16924781.
McGuire, A; Brown, JA; Malone, C; McLaughlin, R; Kerin, MJ (22 de maio de 2015). "Effects of age on the detection and management of breast cancer.". Cancers 7 (2): 908–29. PMC 4491690. PMID 26010605. doi:10.3390/cancers7020815.
Azim, HA; Santoro, L; Russell-Edu, W; Pentheroudakis, G; Pavlidis, N; Peccatori, FA (2012). "Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.". Cancer treatment reviews 38 (7): 834–42. PMID 22785217.

obgyn.net

Pritchard, KI (2009). "Ovarian Suppression/Ablation in Premenopausal ER-Positive Breast Cancer Patients". Oncology 23 (1).

prwatch.org

Landeman, Anne (2001). Center for Media and Democracy, ed. "Pinkwashing: Can Shopping Cure Breast Cancer?".

ranzcog.edu.au

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (novembro de 2014). "Management of the menopause after breast cancer". C-Gyn 15. Arquivado dende o orixinal o 07 de abril de 2016. Consultado o 09 de abril de 2018.

reuters.com

in.reuters.com

Reuters (2015). "Oldest evidence of breast cancer found in Egyptian skeleton". Arquivado dende o orixinal o 27 de marzo de 2015. Consultado o 25 de marzo de 2015.

sabcs.org

Adrian Lee; Carlos Arteaga (14 de decembro de 2009). 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium: Sunday Morning Year-End Review (PDF). Arquivado dende o orixinal (PDF) o 13 de agosto de 2013. Consultado o 03 de abril de 2018.

sespm.es

"Cáncer de Mama Mestatásico: el cáncer invisible". sespm.es. Consultado o 7 de xullo de 2021.

springer.com

link.springer.com

Carroll, KK (1998). "Obesity as a risk factor for certain types of cancer". Lipids 33 (11): 1055–1059. doi:10.1007/s11745-998-0305-8.

stopcancerfund.org

NCI, National Cancer Institute and the National Research Center for Women & Families (2004). "Surgery Choices for Women with Early Stage Breast Cancer" (PDF). Arquivado dende o orixinal (PDF) o 13 de agosto de 2013. Consultado o 30 de agosto de 2015.

thelancet.com

Cuzick, J; Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix AZ, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL (2013). "Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data". The Lancet 381 (9880): 1827–34. PMID 23639488. doi:10.1016/S0140-6736(13)60140-3.
EBCTCG, Early Breast Cancer Trialists' Collaborative Group (2015). "Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials". The Lancet. doi:10.1016/S0140-6736(15)61074-1.
Ramon Luengo-Fernandez, Jose Leal, Alastair Gray, Richard Sullivan (2013). "Economic burden of cancer across the European Union: a population-based cost analysis". The Lancet Oncology 14 (12): 1165–1174. doi:10.1016/S1470-2045(13)70442-X.

touchoncology.com

Bao, Ting; Rudek, Michelle A (2011). "The Clinical Pharmacology of Anastrozole". European Oncology & Haematology 7 (2): 106–8. doi:10.17925/EOH.2011.07.02.106. Arquivado dende o orixinal o 19 de abril de 2012. Consultado o 09 de abril de 2018.

ulusofona.pt

recil.ulusofona.pt

Ribeiro, Joana Inácio (2014). Faculdade de Ciências e Tecnologias da Saúde, ed. Carcinoma mamário: estado da arte (PDF). Lisboa.

up.pt

repositorio-aberto.up.pt

Dias, Ana Margarida de Azevedo (2010). Faculdade de Farmácia da Universidade do Porto, ed. Inibidores da aromatase e cancro da mama: Avaliação biológica de novas moléculas esteroides.

uspreventiveservicestaskforce.org

US Preventative Services Task Force (2009). "Screening for Breast Cancer". Arquivado dende o orixinal o 02 de xaneiro de 2013. Consultado o 24 de decembro de 2012.
"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.". Annals of internal medicine 151 (10): 716–26, W–236. 2009. PMID 19920272. doi:10.1059/0003-4819-151-10-200911170-00008. Arquivado dende o orixinal o 02 de xaneiro de 2013. Consultado o 03 de abril de 2018.

web.archive.org

US Preventative Services Task Force (2009). "Screening for Breast Cancer". Arquivado dende o orixinal o 02 de xaneiro de 2013. Consultado o 24 de decembro de 2012.
International Agency for Research on Cancer (2008). "World Cancer Report" (PDF). Arquivado dende o orixinal (PDF) o 20 de xullo de 2011. Consultado o 26 de febreiro de 2011.
Liga Portuguesa contra o Cancro (2015). "Sinais e sintomas do cancro da mama". Arquivado dende o orixinal o 09 de setembro de 2015. Consultado o 23 de agosto de 2015.
National Cancer Institute (2004). "Metastatic Cancer: Questions and Answers". Arquivado dende o orixinal o 27 de agosto de 2008. Consultado o 6 de febreiro de 2008.
American Cancer Society (2007). "Cancer Facts & Figures 2007" (PDF). Arquivado dende o orixinal (PDF) o 10 de abril de 2007. Consultado o 26 de abril de 2007.
eMedicine (2006). "Breast Cancer Evaluation". Arquivado dende o orixinal o 12 de febreiro de 2008. Consultado o 5 de febreiro de 2008.
Merck Manual (2003). "Breast Disorders: Overview of Breast Disorders". Arquivado dende o orixinal o 03 de outubro de 2011. Consultado o 5 de febreiro de 2008.
American Cancer Society (2005). "Breast Cancer Facts & Figures 2005–2006" (PDF). Arquivado dende o orixinal (PDF) o 13 de xuño de 2007. Consultado o 26 de abril de 2007.
Adrian Lee; Carlos Arteaga (14 de decembro de 2009). 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium: Sunday Morning Year-End Review (PDF). Arquivado dende o orixinal (PDF) o 13 de agosto de 2013. Consultado o 03 de abril de 2018.
American Cancer Society, ed. (4 de maio de 2016). "How is breast cancer classified?". Arquivado dende o orixinal o 22 de xuño de 2016. Consultado o 21 de xuño de 2016.
Bouche, Gauthier; Piccart, Martine; Pestalozzi, Bernhard; Catane, Raphael (2013). Anticancer Fund, ed. Cancro da Mama: Um Guia Para o Doente (PDF) (3ª ed.). p. 12. Arquivado dende o orixinal (PDF) o 06 de setembro de 2015. Consultado o 05 de abril de 2018.
Cancer Research UK (ed.). "Breast Cancer Staging". Arquivado dende o orixinal o 16 de maio de 2016. Consultado o 19 de maio de 2016.
Marmot, M; Atinmo, T; Byers, T; Chen, J; Hirohata, T; Jackson, A; James, W; Kolonel, L; Kumanyika, S; Leitzmann, C; Mann, J; Powers, H; Reddy, K; Riboli, E; Rivera, JA; Schatzkin, A; Seidell, J; Shuker, D; Uauy, R; Willett, W; Zeisel, S (2007). AICR, ed. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective (PDF). World Cancer Research Fund / American Institute for Cancer Research (AICR) Expert Reports 2. Washington, DC. ISBN 9780972252225. Arquivado dende o orixinal (PDF) o 07 de maio de 2016. Consultado o 06 de abril de 2018.
American Cancer Society, ed. (4 de maio de 2016). "Can breast cancer be found early?". Arquivado dende o orixinal o 15 de xuño de 2016. Consultado o 23 de xuño de 2016.
United States Preventive Services Task Force. "Breast Cancer: Screening". Arquivado dende o orixinal o 16 de xuño de 2013. Consultado o 28 de agosto de 2015.
"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.". Annals of internal medicine 151 (10): 716–26, W–236. 2009. PMID 19920272. doi:10.1059/0003-4819-151-10-200911170-00008. Arquivado dende o orixinal o 02 de xaneiro de 2013. Consultado o 03 de abril de 2018.
João Moura Pereira (ed.). Cancro da Mama: Protocolo de diagnóstico, terapêutica e seguimento (PDF). IPO Coimbra. p. 50. Arquivado dende o orixinal (PDF) o 04 de agosto de 2016. Consultado o 07 de abril de 2018.
Massarut, S; Baldassare G, Belleti B, Reccanello S, D'Andrea S, Ezio C, Perin T, Roncadin M, Vaidya JS (2006). "Intraoperative radiotherapy impairs breast cancer cell motility induced by surgical wound fluid". J Clin Oncol 24 (18S): 10611. Arquivado dende o orixinal o 12 de xaneiro de 2012. Consultado o 09 de abril de 2018.
Bao, Ting; Rudek, Michelle A (2011). "The Clinical Pharmacology of Anastrozole". European Oncology & Haematology 7 (2): 106–8. doi:10.17925/EOH.2011.07.02.106. Arquivado dende o orixinal o 19 de abril de 2012. Consultado o 09 de abril de 2018.
Pereira, João Moura; et al. (2012). Instituto Português de Oncologia de Coimbra, ed. Cancro da Mama: Protocolo de diagnóstico, terapêutica e seguimento (PDF). Arquivado dende o orixinal (PDF) o 04 de agosto de 2016. Consultado o 07 de abril de 2018.
Herceptin.com (ed.). "Herceptin (trastuzumab) Adjuvant HER2+ Breast Cancer Therapy Pivotal Studies and Efficacy Data". Arquivado dende o orixinal o 18 de xullo de 2011. Consultado o 8 de maio de 2010.
NCI, National Cancer Institute and the National Research Center for Women & Families (2004). "Surgery Choices for Women with Early Stage Breast Cancer" (PDF). Arquivado dende o orixinal (PDF) o 13 de agosto de 2013. Consultado o 30 de agosto de 2015.
Organización Mundial da Saúde (ed.). "Breast cancer burden". Arquivado dende o orixinal o 06 de setembro de 2015. Consultado o 18 de maio de 2016.
Laurance, Jeremy (29 de setembro de 2006). The Independent, ed. "Breast cancer cases rise 80% since Seventies". London. Arquivado dende o orixinal o 25 de abril de 2008. Consultado o 9 de outubro de 2006.
Imaginis Corporation, ed. (2006). "Breast Cancer: Statistics on Incidence, Survival, and Screening". Arquivado dende o orixinal o 24 de outubro de 2006. Consultado o 9 de outubro de 2006.
Breast Cancer: Breast Cancer in Young Women WebMD. Consultado o 9 de setembro de 2009
Nearly 85% of women diagnosed with breast cancer now survive for 5 year or more Office for National Statistics, 2013
Reuters (2015). "Oldest evidence of breast cancer found in Egyptian skeleton". Arquivado dende o orixinal o 27 de marzo de 2015. Consultado o 25 de marzo de 2015.
Riter, Bob (2010). Cancer Resource Center of the Finger Lakes, ed. "History of Breast Cancer Advocacy". Arquivado dende o orixinal o 23 de xuño de 2013. Consultado o 29 de xuño de 2013.

webmd.com

WebMD. "Breast Cancer and Mammograms". Consultado o 24 de decembro de 2012.

who.int

OMS, Organização Mundial de Saúde (201). "WHO Disease and injury country estimates". Consultado o 30 de agosto de 2015.
Organización Mundial da Saúde (ed.). "Breast cancer burden". Arquivado dende o orixinal o 06 de setembro de 2015. Consultado o 18 de maio de 2016.

wkhealth.com

meta.wkhealth.com

Afonso, N; Bouwman D (2008). "Lobular carcinoma in situ". Eur. J. Cancer Prev. 17 (4): 312–6. PMID 18562954. doi:10.1097/CEJ.0b013e3282f75e5d.

worldcat.org

Sulik, Gayle A. (2010). Pink Ribbon Blues: How Breast Cancer Culture Undermines Women's Health. Oxford University Press. pp. 200–3. ISBN 0-19-974045-3. OCLC 535493589.
Arnst, Catherine (2007). Bloomberg Businessweek, ed. "A Gender Gap in Cancer". ISSN 0007-7135.